Valuation: Zalicus Inc

Market Cap 746K 665K 616K 558K 1.05M 70.72M 1.06M 7.37M 2.9M 37.01M 2.8M 2.74M 118M P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -15.94M -14.19M -13.16M -11.92M -22.41M -1.51B -22.73M -157M -61.88M -790M -59.77M -58.53M -2.52B EV / Sales 2014
14,770,294,750x
EV / Sales 2015 83,658,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%-6.46%+52.86%+71.34% 65.83B
+1.92%+8.89%+12.90%+82.75% 51.87B
+6.91%+6.41%+9.61%+73.07% 51.2B
+0.74%+2.15%+30.95%+43.43% 43.76B
+3.87%+9.73%+21.52%+142.33% 42.09B
+7.91%+1.34%+263.31%+577.76% 39.04B
-0.40%+9.42%+18.44%+59.06% 34B
+3.84%-4.94%+42.35%+8.92% 25.2B
+2.36%+4.62%+24.20%+31.02% 22.8B
Average +3.10%+0.51%+52.90%+121.07% 41.76B
Weighted average by Cap. +3.05%+0.62%+51.69%+122.72%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.2 0.02 0.01 0.63 0.7 0.62 0.58 0.52 0.99 66.43 1 6.93 2.72 34.76 2.63 2.57 110.96
Net income -41.84M -37.26M -34.56M -31.29M -58.85M -3.97B -59.68M -413M -162M -2.07B -157M -154M -6.62B -52.19M -46.48M -43.1M -39.03M -73.4M -4.95B -74.44M -516M -203M -2.59B -196M -192M -8.26B
Net Debt -14.18M -12.63M -11.71M -10.6M -19.94M -1.34B -20.23M -140M -55.06M -703M -53.19M -52.08M -2.24B -16.68M -14.86M -13.78M -12.47M -23.46M -1.58B -23.79M -165M -64.77M -827M -62.57M -61.27M -2.64B
Logo Zalicus Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-